Covid-19 – Page 19 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2022-04-02

For children aged under 5, the incidence rate of SARS-CoV-2 infection is higher with the omicron versus the delta variant

For children aged under 5, the incidence rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was higher with the omicron variant versus the delta variant, according to a research letter published online April 1 in JAMA Pediatrics. Lindsey Wang, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues examined incidence

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-30

SARS-CoV-2 innate defense system: the role of neutrophil and epithelial defensins

One of the most important layers of our body’s defense against SARS-CoV-2 lies in our innate immune system. The innate immune system protects our body from microbes, viruses, bacteria, and parasites that we have not previously encountered. While much of public attention and awareness of human immunity is focused on adaptive or learned immunity, innate

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-30

Lung Damage May Persist Long After COVID-19 Pneumonia

Evidence from the SARS-CoV-1 outbreak of 2002 to 2004 shows that lung abnormalities may remain detectable even after decades, but do not show any progression, according to study co-author Leonhard Gruber, MD, from the Department of Radiology at Innsbruck Medical University. Recent studies, though, have shown a risk of progression of lung abnormalities such as

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-26

COVID-19 infection linked to higher risk of neuropathy

Symptoms persisted for months after a positive test for COVID-19 Adding to a growing body of evidence that, for many, problems related to COVID-19 linger longer than the initial infection, researchers at Washington University School of Medicine in St. Louis have found that some people infected during the pandemic’s early months experienced peripheral neuropathy —

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-25

Most anti-PF4 antibodies in Covid-19 vaccine-induced immune thrombotic thrombocytopenia are transient

Platelet-activating anti-PF4 antibodies in VITT are transient in >90% of patients. Likely VITT patients can safely receive a second vaccination shot with an mRNA vaccine, independent of their VITT-antibody status. Vaccine-induced thrombotic thrombocytopenia (VITT) is triggered by vaccination against COVID-19 with adenovirus vector vaccines (ChAdOx1 nCoV-19; Ad26.COV2-S). In this observational study, were followed VITT patients

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-25

“Deltacron” a combination of the delta (AY.4) and BA.1 omicron variants named by the WHO as the BA.1 x AY.4 recombinant.

A combination of the delta (AY.4) and BA.1 omicron variants has been named by the World Health Organization as the BA.1 x AY.4 recombinant. First detected in France in January 2022, it has since picked up the nickname “deltacron”1 How does a recombinant emerge? Recombinants can emerge when multiple variants infect the same person at

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-23

American College of Cardiology Issues Clinical Guidance on CardioVascular Consequences of COVID-19

A new Expert Consensus Decision Pathway released by the ACC addresses the evaluation and management of some of the more common cardiovascular sequelae in adults with COVID-19. The Pathway, published March 16 in the Journal of the American College of Cardiology, specifically addresses myocarditis and other types of myocardial involvement, patient-centered approaches for long COVID, and

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-23

Increased risk of type 2 diabetes after Covid-19, study of DZD finds

People who have had Covid-19 are at increased risk of developing type 2 diabetes. This is the result of a study by DDZ, DZD and IQVIA, which has now been published in Diabetologia. Studies show that the human pancreas can also be a target of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2 virus). Following

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-18

Excess Neuropeptides Disrupt Lung Function in Infant Disease and COVID-19

UC San Diego study identifies lung neuroendocrine cells as drivers of developmental lung disease; similar mechanism may contribute to COVID-19 symptoms COVID-19 has put a spotlight on the pulmonary and nervous systems, but there is still much to learn about how they interact. Researchers at University of California San Diego School of Medicine recently explored

No Comments InCovid-19

PIER MARIA FORNASARI
2022-03-12

Genetic study gives insights into severe Covid-19

The world’s largest study of the genetics of critical Covid-19, involving more than 57,000 people, has revealed fresh details about some of the biological mechanisms behind the severe form of the disease. Some 16 new genetic variants associated with severe Covid-19, including some related to blood clotting, immune response and intensity of inflammation, have been

No Comments InCovid-19

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Category Covid-19

For children aged under 5, the incidence rate of SARS-CoV-2 infection is higher with the omicron versus the delta variant

SARS-CoV-2 innate defense system: the role of neutrophil and epithelial defensins

Lung Damage May Persist Long After COVID-19 Pneumonia

COVID-19 infection linked to higher risk of neuropathy

Most anti-PF4 antibodies in Covid-19 vaccine-induced immune thrombotic thrombocytopenia are transient

“Deltacron” a combination of the delta (AY.4) and BA.1 omicron variants named by the WHO as the BA.1 x AY.4 recombinant.

American College of Cardiology Issues Clinical Guidance on CardioVascular Consequences of COVID-19

Increased risk of type 2 diabetes after Covid-19, study of DZD finds

Excess Neuropeptides Disrupt Lung Function in Infant Disease and COVID-19

Genetic study gives insights into severe Covid-19